Barbara Kahn, Director at DEXCOM INC (DXCM), sold 6,732 shares at $440.85 ($3.0M) on 2022-02-10, disclosed to the SEC on 2022-02-14.
Open-market sale of $3.0M DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $428.55 | 100 | $43K | 1.4% |
| 2 | $430.06 | 100 | $43K | 1.4% |
| 3 | $434.36 | 1,147 | $498K | 16.8% |
| 4 | $434.36 | 1,147 | $498K | 16.8% |
| 5 | $435.64 | 100 | $44K | 1.5% |
| 6 | $438.21 | 100 |
| $44K |
| 1.5% |
| 7 | $440.85 | 200 | $88K | 3.0% |
| 8 | $442.18 | 476 | $210K | 7.1% |
| 9 | $442.18 | 476 | $210K | 7.1% |
| 10 | $443.56 | 443 | $196K | 6.6% |
| 11 | $443.56 | 443 | $196K | 6.6% |
| 12 | $444.80 | 400 | $178K | 6.0% |
| 13 | $445.85 | 200 | $89K | 3.0% |
| 14 | $447.35 | 200 | $89K | 3.0% |
| 15 | $448.98 | 400 | $180K | 6.0% |
| 16 | $450.07 | 200 | $90K | 3.0% |
| 17 | $451.29 | 200 | $90K | 3.0% |
| 18 | $452.50 | 400 | $181K | 6.1% |
| Total | $441.06 avg | 6,732 | $3.0M | 100% |
| Filing → |
| DXCM | SELL | 2019-01-16 | $3.0M | — | Filing → |
| DXCM | SELL | 2017-11-20 | $164K | — | Filing → |
| DXCM | SELL | 2017-03-16 | $232K | — | Filing → |